Susan Mahony
CIK 1463321 · SVP & Pres., Lilly Oncology · last filed 2026-06-10
Susan Mahony is a SVP & Pres., Lilly Oncology who has filed 62 SEC Form 4 insider transactions across 5 companies since 2010. The most recent filing, for AXSM, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$13.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $63.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$63.16M
5
62
-$13.39M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AXSM | Director | 829 | $255.17 | $211.5K | -$145.0K | 7 | 2026-06-10 |
| ASMB | Director | — | $22.96 | — | $0 | 10 | 2026-06-05 |
| ZYME | Director | — | $22.88 | — | $0 | 6 | 2026-01-12 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Director | 0 | $116.30 | $0 | $0 | 7 | 2023-10-06 |
| LLY | SVP & Pres., Lilly Oncology | 55,559 | $1133.00 | $62.95M | -$13.25M | 32 | 2019-02-01 |
Recent Filings
62 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | AXSM | Mixed | +829 | -$145.0K | EDGAR |
| 2026-06-09 | AXSM | Grant (A) | — | $0 | EDGAR |
| 2026-06-05 | ASMB | Grant (A) | — | $0 | EDGAR |
| 2026-01-12 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2025-06-10 | AXSM | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | ASMB | Grant (A) | — | $0 | EDGAR |
| 2025-02-25 | AXSM | Grant (A) | — | $0 | EDGAR |
| 2024-12-12 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2024-06-11 | AXSM | Grant (A) | — | $0 | EDGAR |
| 2024-05-30 | ASMB | Grant (A) | — | $0 | EDGAR |